Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The evolving population of immunocompromised children.

E A Albano1, P A Pizzo

  • 1Department of Hematology-Oncology, Children's Hospital National Medical Center, Washington, DC.

The Pediatric Infectious Disease Journal
|May 1, 1988
PubMed
Summary

The study defines the immunocompromised host, highlighting infections in children with congenital deficiencies, cancer, autoimmune diseases, and HIV. Management focuses on addressing immunodeficiency and preventing/treating infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Work-family issues and perceptions of stress among pediatric faculty and house staff.

Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association·2002
Same author

Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS.

The Journal of infectious diseases·2001
Same author

Will current training programs prepare pediatricians to meet the health care needs of children in the 21st century? An opinion.

The Journal of pediatrics·2001
Same author

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.

The Journal of infectious diseases·2001
Same author

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Chest radiography versus chest CT in the evaluation for pulmonary metastases in patients with Wilms' tumor: a retrospective review.

Pediatric radiology·2000

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • The concept of the immunocompromised host originated from congenital immune deficiencies.
  • Therapeutic advancements in cancer and autoimmune diseases have increased the population of immunocompromised children.
  • Human immunodeficiency virus (HIV) infection is emerging as a predominant cause of immunocompromise in pediatric populations.

Purpose of the Study:

  • To define the immunocompromised host in pediatrics.
  • To identify the causes and patterns of infections in immunocompromised children.
  • To outline management goals for immunocompromised children, focusing on restoring immune function and preventing/treating infections.

Main Methods:

  • Review of historical definitions and evolving populations of immunocompromised hosts.

Related Experiment Videos

  • Analysis of infection patterns relative to immune system targets affected by various causes of immunodeficiency.
  • Identification of dual management goals: addressing the immunodeficiency and managing infectious complications.

    • Main Results:

    • Immunocompromised hosts encompass children with congenital deficiencies, iatrogenic immunosuppression (cancer/autoimmune therapy), and HIV infection.
    • Infection incidence and patterns in immunocompromised children correlate with the specific components of the immune system affected.
    • Management strategies must address both the underlying immunodeficiency and the associated spectrum of infections.

    Conclusions:

    • The definition and population of immunocompromised children have evolved significantly.
    • Understanding the specific immune defects is crucial for predicting and managing infectious risks.
    • A dual approach to management, focusing on immune restoration and infection control, is essential for improving outcomes in immunocompromised children.